BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2792447)

  • 1. [Cardio- and hemodynamics of dogs during the development of postischemic shock reaction].
    Sagach VF; Dmitrieva AV
    Fiziol Zh (1978); 1989; 35(4):9-15. PubMed ID: 2792447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of prostaglandins in the development of cardio- and hemodynamic disorders in postischemic shock].
    Sagach VF; Zhukova AV
    Fiziol Zh (1978); 1991; 37(2):25-31. PubMed ID: 1905243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the eicosanoids in the development of a postischemic shock reaction].
    Zhukova AV; Sahach VF
    Fiziol Zh (1994); 1996; 42(1-2):3-9. PubMed ID: 8991711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock.
    Oei HH; Zoganas HC; Sakane Y; Robson RD; Glenn TM
    Circ Shock; 1986; 18(2):95-106. PubMed ID: 3753907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction].
    Sagach VF; Dmitrieva AV
    Fiziol Zh (1978); 1990; 36(4):8-14. PubMed ID: 2172032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal prostacyclin and thromboxane production in irreversible hemorrhagic shock.
    Alemayehu A; Sawmiller D; Chou BS; Chou CC
    Circ Shock; 1987; 23(2):119-30. PubMed ID: 3315288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of eicosanoids in the postischemic shock development.
    Zhukova AV; Sagach VF
    Pol J Pharmacol; 1996; 48(1):23-9. PubMed ID: 9112624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of indomethacin on the development of cardiac and hemodynamic disorders in shock of immune origin].
    Sagach VF
    Farmakol Toksikol; 1987; 50(3):104-6. PubMed ID: 2440716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardio- and hemodynamics of dogs in exposure of the heart to immune complexes].
    Sagach VF; Shablovskaia OV
    Biull Eksp Biol Med; 1985 May; 99(5):549-52. PubMed ID: 4005408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sodium thiosulfate in the treatment of early postischemic disorders].
    Oksman TM; LevandovskiÄ­ IV; Epishin IuN; Vrana M; Blazhek Z
    Biull Eksp Biol Med; 1981 Sep; 92(9):275-8. PubMed ID: 7295979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
    Sagach VF; Dmitrieva AV; Braquet P
    Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model.
    Sunose Y; Takeyoshi I; Tsutsumi H; Kawata K; Tokumine M; Iwazaki S; Tomizawa N; Ohwada S; Matsumoto K; Morishita Y
    J Surg Res; 2001 Feb; 95(2):167-73. PubMed ID: 11162041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypercarbic acidotic reperfusion on recovery of myocardial function after cardioplegic ischemia in neonatal lambs.
    Nomura F; Aoki M; Forbess JM; Mayer JE
    Circulation; 1994 Nov; 90(5 Pt 2):II321-7. PubMed ID: 7955274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in prostacyclin and thromboxane A2 in coronary circulation, and their relation to coronary hemodynamics during reperfusion after global ischemia in canine hearts].
    Nomura F
    Nihon Kyobu Geka Gakkai Zasshi; 1985 Nov; 33(11):2109-17. PubMed ID: 3912439
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial changes in prostacyclin and thromboxane A2 induced by ginsenosides in myocardial infarction and reperfusion injury in dogs.
    Fang YX; Shen N; Chen X
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):226-30. PubMed ID: 2954367
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1984 Apr; 81(4):675-84. PubMed ID: 6547068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
    Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiopulmonary effects of halothane in hypovolemic dogs.
    Pascoe PJ; Haskins SC; Ilkiw JE; Patz JD
    Am J Vet Res; 1994 Jan; 55(1):121-6. PubMed ID: 8141484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.